Literature DB >> 28436953

Disruption of direct 3D telomere-TRF2 interaction through two molecularly disparate mechanisms is a hallmark of primary Hodgkin and Reed-Sternberg cells.

Hans Knecht1, Nathalie A Johnson1, Tina Haliotis1,2, Daniel Lichtensztejn3, Sabine Mai3.   

Abstract

In classical Hodgkin's lymphoma (cHL), specific changes in the 3D telomere organization cause progression from mononuclear Hodgkin cells (H) to multinucleated Reed-Sternberg cells (RS). In a post-germinal center B-cell in vitro model, permanent latent membrane protein 1 (LMP1) expression, as observed in Epstein-Barr virus (EBV)-associated cHL, results in multinuclearity and complex chromosomal aberrations through downregulation of key element of the shelterin complex, the telomere repeat binding factor 2 (TRF2). Thus, we hypothesized that the three-dimensional (3D) telomere-TRF2 interaction was progressively disturbed during transition from H to RS cells. To this end, we developed and applied for the first time a combined quantitative 3D TRF2-telomere immune fluorescent in situ hybridization (3D TRF2/Telo-Q-FISH) technique to monolayers of primary H and RS cells, and adjacent benign internal control lymphocytes of lymph node biopsy suspensions from diagnostic lymph node biopsies of 14 patients with cHL. We show that H and RS cells are characterized by two distinct patterns of disruption of 3D telomere-TRF2 interaction. Disruption pattern A is defined by massive attrition of telomere signals and a considerable increase of TRF2 signals not associated with telomeres. This pattern is restricted to EBV-negative cHL. Disruption pattern B is defined by telomere de-protection due to an impressive loss of TRF2 signals, physically linked to telomeres. This pattern is typical of, but is not restricted to, LMP1+EBV-associated cHL. In the disruption pattern B group, so-called 'ghost' end-stage RS cells, void of both TRF2 and telomere signals, were identified, whether or not associated with EBV. Our findings demonstrate that two molecularly disparate mechanisms converge on the level of 3D telomere-TRF2 interaction in the formation of RS cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28436953     DOI: 10.1038/labinvest.2017.33

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  50 in total

1.  Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2.

Authors:  Stefan Joos; Martin Granzow; Heidi Holtgreve-Grez; Reiner Siebert; Lana Harder; José I Martín-Subero; Jürgen Wolf; Martyna Adamowicz; Thomas F E Barth; Peter Lichter; Anna Jauch
Journal:  Int J Cancer       Date:  2003-02-10       Impact factor: 7.396

2.  Persistent telomere damage induces bypass of mitosis and tetraploidy.

Authors:  Teresa Davoli; Eros Lazzerini Denchi; Titia de Lange
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

3.  Characterizing the three-dimensional organization of telomeres.

Authors:  B J Vermolen; Y Garini; S Mai; V Mougey; T Fest; T C-Y Chuang; A Y-C Chuang; L Wark; I T Young
Journal:  Cytometry A       Date:  2005-10       Impact factor: 4.355

4.  DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion.

Authors:  Giulia B Celli; Titia de Lange
Journal:  Nat Cell Biol       Date:  2005-06-19       Impact factor: 28.824

5.  LMP1 mediates multinuclearity through downregulation of shelterin proteins and formation of telomeric aggregates.

Authors:  Valérie Lajoie; Bruno Lemieux; Bassem Sawan; Daniel Lichtensztejn; Zelda Lichtensztejn; Raymund Wellinger; Sabine Mai; Hans Knecht
Journal:  Blood       Date:  2015-01-07       Impact factor: 22.113

6.  3D Telomere FISH defines LMP1-expressing Reed-Sternberg cells as end-stage cells with telomere-poor 'ghost' nuclei and very short telomeres.

Authors:  Hans Knecht; Bassem Sawan; Zelda Lichtensztejn; Daniel Lichtensztejn; Sabine Mai
Journal:  Lab Invest       Date:  2010-02-08       Impact factor: 5.662

7.  Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia.

Authors:  Marcia Bellon; Abhik Datta; Megan Brown; Jean-Francois Pouliquen; Pierre Couppie; Mirdad Kazanji; Christophe Nicot
Journal:  Int J Cancer       Date:  2006-11-01       Impact factor: 7.396

8.  Telomerase activity in reactive and neoplastic lymphoid tissues: infrequent detection of activity in Hodgkin's disease.

Authors:  P Brousset; T al Saati; N Chaouche; R C Zenou; D Schlaifer; S Chittal; G Delsol
Journal:  Blood       Date:  1997-01-01       Impact factor: 22.113

9.  Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion.

Authors:  Francis Rodier; Jean-Philippe Coppé; Christopher K Patil; Wieteke A M Hoeijmakers; Denise P Muñoz; Saba R Raza; Adam Freund; Eric Campeau; Albert R Davalos; Judith Campisi
Journal:  Nat Cell Biol       Date:  2009-07-13       Impact factor: 28.824

10.  Mir-23a induces telomere dysfunction and cellular senescence by inhibiting TRF2 expression.

Authors:  Zhenhua Luo; Xuyang Feng; Haoli Wang; Weiyi Xu; Yong Zhao; Wenbin Ma; Songshan Jiang; Dan Liu; Junjiu Huang; Zhou Songyang
Journal:  Aging Cell       Date:  2015-03-06       Impact factor: 9.304

View more
  6 in total

Review 1.  LMP1 and Dynamic Progressive Telomere Dysfunction: A Major Culprit in EBV-Associated Hodgkin's Lymphoma.

Authors:  Hans Knecht; Sabine Mai
Journal:  Viruses       Date:  2017-06-27       Impact factor: 5.048

Review 2.  The Role of Immune Checkpoint Inhibitors in Classical Hodgkin Lymphoma.

Authors:  Nicholas Meti; Khashayar Esfahani; Nathalie A Johnson
Journal:  Cancers (Basel)       Date:  2018-06-15       Impact factor: 6.639

3.  The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical Outcomes.

Authors:  Radhia M'kacher; Corina Cuceu; Mustafa Al Jawhari; Luc Morat; Monika Frenzel; Grace Shim; Aude Lenain; William M Hempel; Steffen Junker; Theodore Girinsky; Bruno Colicchio; Alain Dieterlen; Leonhard Heidingsfelder; Claire Borie; Noufissa Oudrhiri; Annelise Bennaceur-Griscelli; Olivier Moralès; Sarah Renaud; Zoé Van de Wyngaert; Eric Jeandidier; Nadira Delhem; Patrice Carde
Journal:  Cancers (Basel)       Date:  2018-05-30       Impact factor: 6.639

4.  Measurement of Telomere Length in Colorectal Cancers for Improved Molecular Diagnosis.

Authors:  Eric Le Balc'h; Nathalie Grandin; Marie-Véronique Demattei; Serge Guyétant; Anne Tallet; Jean-Christophe Pagès; Mehdi Ouaissi; Thierry Lecomte; Michel Charbonneau
Journal:  Int J Mol Sci       Date:  2017-08-29       Impact factor: 5.923

5.  Distinct 3D Structural Patterns of Lamin A/C Expression in Hodgkin and Reed-Sternberg Cells.

Authors:  Fabio Contu; Aline Rangel-Pozzo; Peter Trokajlo; Landon Wark; Ludger Klewes; Nathalie A Johnson; Tina Petrogiannis-Haliotis; John G Gartner; Yuval Garini; Roberta Vanni; Hans Knecht; Sabine Mai
Journal:  Cancers (Basel)       Date:  2018-08-24       Impact factor: 6.639

Review 6.  Molecular Pathogenesis of Hodgkin Lymphoma: Past, Present, Future.

Authors:  Marc Bienz; Salima Ramdani; Hans Knecht
Journal:  Int J Mol Sci       Date:  2020-09-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.